Citation Tools

PDF
The impact of 12 months treatment with ivacaftor on Scottish paediatric patients with cystic fibrosis with the G551D mutation: a review

Download to a citation manager

Cite this article as:
Dryden C, Wilkinson J, Young D on behalf of the Scottish Paediatric Cystic Fibrosis Managed Clinical Network (SPCFMCN), et al
The impact of 12 months treatment with ivacaftor on Scottish paediatric patients with cystic fibrosis with the G551D mutation: a review